Literature DB >> 33375045

Molecular MR Imaging of Prostate Cancer.

Avan Kader1,2, Julia Brangsch1,3, Jan O Kaufmann1,4,5, Jing Zhao1, Dilyana B Mangarova1,6, Jana Moeckel1, Lisa C Adams1, Ingolf Sack1, Matthias Taupitz1, Bernd Hamm1, Marcus R Makowski1,7,8.   

Abstract

This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.

Entities:  

Keywords:  magnetic resonance imaging; molecular imaging; molecular marker; prostate cancer

Year:  2020        PMID： 33375045      PMCID： PMC7822017          DOI： 10.3390/biomedicines9010001

Source DB:  PubMed          Journal:  Biomedicines        ISSN： 2227-9059


  117 in total

Review 1.  Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer.

Authors:  Geert J L H van Leenders; Jack A Schalken
Journal:  Crit Rev Oncol Hematol       Date:  2003-06-27       Impact factor: 6.312

2.  Magnetic resonance imaging for prostate cancer clinical application.

Authors:  Bing Li; Yong Du; Hanfeng Yang; Yayong Huang; Jun Meng; Dongmei Xiao
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

3.  Family history and the risk of prostate cancer.

Authors:  G D Steinberg; B S Carter; T H Beaty; B Childs; P C Walsh
Journal:  Prostate       Date:  1990       Impact factor: 4.104

4.  Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.

Authors:  Tsai-Ling Lu; Yi-Fen Huang; Li-Ru You; Nai-Chen Chao; Fang-Yi Su; Junn-Liang Chang; Chun-Ming Chen
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

5.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

6.  Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.

Authors:  Aurang Z Khawaja; Deirdre B Cassidy; Julien Al Shakarchi; Damian G McGrogan; Nicholas G Inston; Robert G Jones
Journal:  Insights Imaging       Date:  2015-08-08

7.  GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.

Authors:  Fan Pu; Jingjuan Qiao; Shenghui Xue; Hua Yang; Anvi Patel; Lixia Wei; Khan Hekmatyar; Mani Salarian; Hans E Grossniklaus; Zhi-Ren Liu; Jenny J Yang
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

8.  The role of the histone H3 variant CENPA in prostate cancer.

Authors:  Anjan K Saha; Rafael Contreras-Galindo; Yashar S Niknafs; Matthew Iyer; Tingting Qin; Karthik Padmanabhan; Javed Siddiqui; Monica Palande; Claire Wang; Brian Qian; Elizabeth Ward; Tara Tang; Scott A Tomlins; Scott D Gitlin; Maureen A Sartor; Gilbert S Omenn; Arul M Chinnaiyan; David M Markovitz
Journal:  J Biol Chem       Date:  2020-05-05       Impact factor: 5.157

9.  Endothelial cells promote metastasis of prostate cancer by enhancing autophagy.

Authors:  Ruizhe Zhao; Xiaoyu Bei; Boyu Yang; Xiaohai Wang; Chenyi Jiang; Fei Shi; Xingjie Wang; Yiping Zhu; Yifeng Jing; Bangmin Han; Shujie Xia; Qi Jiang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-10

10.  Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.

Authors:  Zheng Zhang; Ciman Chai; Tianyu Shen; Xiaoqing Li; Junpeng Ji; Changying Li; Zhiqun Shang; Yuanjie Niu
Journal:  Dis Markers       Date:  2019-09-03       Impact factor: 3.434
View more
  1 in total

1.  Segmentation of the prostate, its zones, anterior fibromuscular stroma, and urethra on the MRIs and multimodality image fusion using U-Net model.

Authors:  Seyed Masoud Rezaeijo; Shabnam Jafarpoor Nesheli; Mehdi Fatan Serj; Mohammad Javad Tahmasebi Birgani
Journal:  Quant Imaging Med Surg       Date:  2022-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.